Traws Pharma (TRAW) Misses Q2 EPS by 11c
Traws Pharma (NASDAQ: TRAW) reported Q2 EPS of ($0.11). Revenue for the quarter came in at $2.73 million.
For earnings history and earnings-related data on Traws Pharma (TRAW) click here.
Traws Pharma (NASDAQ: TRAW) reported Q2 EPS of ($0.11). Revenue for the quarter came in at $2.73 million.
For earnings history and earnings-related data on Traws Pharma (TRAW) click here.